132 related articles for article (PubMed ID: 36678586)
1. Refractory Age-Related Macular Degeneration Due to Concurrent Central Serous Chorioretinopathy in Previously Well-Controlled Eyes.
Hara C; Wakabayashi T; Sayanagi K; Nishida K
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678586
[No Abstract] [Full Text] [Related]
2. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
[TBL] [Abstract][Full Text] [Related]
3. Identification of macular neovascularization in central serous chorioretinopathy using swept-source OCT angiography.
Staropoli PC; Iyer P; Gregori G; Rosenfeld PJ; Flynn HW
Am J Ophthalmol Case Rep; 2023 Jun; 30():101843. PubMed ID: 37092114
[TBL] [Abstract][Full Text] [Related]
4. SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome.
Zatreanu L; Freund KB; Leong BCS; Yu HG; Teke MY; Yzer S; Sadda SR; Sarraf D
Retina; 2020 Aug; 40(8):1456-1470. PubMed ID: 31613838
[TBL] [Abstract][Full Text] [Related]
5. Variation in Visual Outcome to Anti-Vascular Endothelial Growth Factors in Choroidal Neovascular Membrane Developing in Eyes with Previously Untreated Versus Focal Laser-Treated Central Serous Chorioretinopathy.
Roy R; Saurabh K; Das D; Panigrahi PK; Das S; Pal SS; Jain A
Semin Ophthalmol; 2017; 32(6):781-786. PubMed ID: 27533737
[TBL] [Abstract][Full Text] [Related]
6. Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy.
Keidel LF; Schworm B; Priglinger SG; Siedlecki J
Case Rep Ophthalmol; 2021; 12(1):116-123. PubMed ID: 33976667
[TBL] [Abstract][Full Text] [Related]
7. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
Romdhane K; Zola M; Matet A; Daruich A; Elalouf M; Behar-Cohen F; Mantel I
Br J Ophthalmol; 2020 Jul; 104(7):910-916. PubMed ID: 31615761
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy.
Sahoo NK; Mishra SB; Iovino C; Singh SR; Munk MR; Berger L; Peiretti E; Chhablani J
Br J Ophthalmol; 2019 Nov; 103(11):1615-1618. PubMed ID: 30602447
[TBL] [Abstract][Full Text] [Related]
9. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
Moon DRC; Lee DK; Kim SH; You YS; Kwon OW
Korean J Ophthalmol; 2015 Aug; 29(4):226-32. PubMed ID: 26240506
[TBL] [Abstract][Full Text] [Related]
10. Using optical coherence tomography angiography in assessment of the anti-vascular endothelial growth factor effect for pathological vascular tissue in age-related macular degeneration and polypoidal choroidal vasculopathy.
Shen YS; Cheng CK
Eur J Ophthalmol; 2021 May; 31(3):1267-1280. PubMed ID: 32228025
[TBL] [Abstract][Full Text] [Related]
11. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
[TBL] [Abstract][Full Text] [Related]
12. Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept.
Hara C; Wakabayashi T; Fukushima Y; Sayanagi K; Kawasaki R; Sato S; Sakaguchi H; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2559-2569. PubMed ID: 31482277
[TBL] [Abstract][Full Text] [Related]
13. Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward.
Lazzeri S; Ripandelli G; Sartini MS; Parravano M; Varano M; Nardi M; Di Desidero T; Orlandi P; Bocci G
Angiogenesis; 2015 Oct; 18(4):397-432. PubMed ID: 26346237
[TBL] [Abstract][Full Text] [Related]
14. A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration.
Park DH; Sun HJ; Lee SJ
Int Ophthalmol; 2017 Oct; 37(5):1205-1214. PubMed ID: 27826933
[TBL] [Abstract][Full Text] [Related]
15. Multimodal Imaging in the Management of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy.
Hagag AM; Chandra S; Khalid H; Lamin A; Keane PA; Lotery AJ; Sivaprasad S
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32575806
[TBL] [Abstract][Full Text] [Related]
16. Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration.
Shah VP; Shah SA; Mrejen S; Freund KB
Retina; 2014 Jul; 34(7):1281-8. PubMed ID: 24695062
[TBL] [Abstract][Full Text] [Related]
17. Nonhomogenous Hyperreflectivity in the Choriocapillaris Layer on Optical Coherence Tomography Angiography Implies Early Treatment with Anti-VEGF for Central Serous Chorioretinopathy.
Zhao Z; Zhang J
Ophthalmic Res; 2022; 65(5):506-515. PubMed ID: 35405684
[TBL] [Abstract][Full Text] [Related]
18. Meticulous multimodal analysis of aflibercept therapy for submacular vascularized pigment epithelial detachment associated with neovascular AMD in a prospective case series, the EVEN study.
Chan CK; Sarraf D; Abraham P; Lalezary M; Lin SG; Chen X; Nittala MG; Sadda S
Am J Ophthalmol Case Rep; 2020 Dec; 20():100916. PubMed ID: 33024885
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration.
Massamba N; Dirani A; Butel N; Fardeau C; Bodaghi B; Ingram A; Lehoang P
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):61-67. PubMed ID: 27397583
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability.
Nomura Y; Yanagi Y
Jpn J Ophthalmol; 2015 Jul; 59(4):261-5. PubMed ID: 25983109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
